Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 3OTHER 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 13Endometrial Neoplasms 2Carcinoma, Ductal, Breast 2Peritoneal Neoplasms 1Fallopian Tube Neoplasms 1Cystadenocarcinoma, Serous 1Carcinoma, Lobular 1Breast Neoplasms, Male 1Breast Neoplasm Female 1Breast Carcinoma In Situ 1Breast Cancer Invasive Nos 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Tamoxifen 2Letrozole 2Brachytherapy 2Radiotherapy, Conformal 1Pharmacogenomic Testing 1Medroxyprogesterone 1Magnetic Resonance Spectroscopy 1Estrogens, Conjugated (USP) 1Docetaxel 1Celecoxib 1Capecitabine 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Ductal, Breast × Letrozole × Clear all
NCT00433589 2022-11-17

MINDACT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
6,600 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00004205 2017-12-12

BIG 1-98

ETOP IBCSG Partners Foundation

Phase 3 Completed
8,028 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡